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Summary. The detection of structural and numerical 
chromosomal aberrations is an important part of the 
characterization of tumors and genetic diseases. The 
direct demonstration of DNA sequences in interphase 
nuclei and metaphases by fluorescence in situ 
hybridization (FISH) has been termed interphase 
cytogenetics. It has been proven as a powerful technique 
to detect specific aberrations in a wide variety of cell 
types, including paraffin-embedded tissue. Nowadays a 
standard method in leukemia and lymphoma, interphase 
cytogenetics contributes mainly to the diagnosis in these 
tumors and helps to classify soft tissue tumors. 
Therefore FISH is mandatory for the choice of therapy 
in these tumors. In contrast to the aforementioned, up to 
now, the value of FISH in solid tumors is mostly limited 
to pure research and contributes in this way to our 
understanding of tumor biology. But with the use of 
paraffin-embedded tissue and the first results obtained, it 
seems very likely that a direct correlation between 
histological classification and cytogenetic characteristics 
of solid tumors can be achieved in the near future. This 
information might not only provide insights into tumor 
biology, but could also contribute to a different tumor 
classification, a sort of risk estimation, where we might 
predict the possible biological behavior of solid tumors. 
This could greatly influence further therapeutic decisions 
thus establishing the FISH technique as an indisputable 
part in the diagnosis of solid tumors. 
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Introduction 
More than ten years ago, fluorescence in situ 
hybridization (FISH) was established as a tool for the 
detection of chromosomal aberrations (Cremer et al., 
1986; Pinkel et al., 1986a,b). This direct demonstration 
of specific DNA sequences in interphase nuclei was also 
named interphase cytogenetics or molecular cytogenetics 
and was at first limited to cell lines and to the detection 
of the centromeric region of the chromosomes with 
DNA probes hybridizing to the repetitive sequences of 
the alphoid DNA family (Cremer et al., 1986). With 
further development of the technique, the next targets 
were the repeated sequences in the telomeric regions at 
the short and long arms of chromosomes (Buroker et al., 
1987;  Moyzis et al., 1988), which consist,  l ike 
centromeric DNA, of almost uninterrupted repetitions of 
monomer sequences. These provide a large hybridization 
target for small probes resulting in a good fluorescence 
signal. Even the variation in the repeat number among 
individuals shown by Weier and Gray (1992) does not 
affect the sensitivity of FISH as demonstrated in a 
comprehensive clinical study (Ward et al., 1993). 
One of the most important advantages of interphase 
cytogenetics over karyotypic analysis is the possibility to 
work with interphase cells; that is, with native material. 
Metaphases and cell cultures are not required. Therefore, 
a direct investigation of cellular material like blood 
smears or tissue sections is practicable, without the risk 
of cell selection through culturing. In addition, the 
possible analysis of sub-populations facilitates the work 
with genetically heterogeneous tumors. All these 
advantages of molecular cytogenetics lead to  an 
intensive use of this technique in the investigation of 
leukemia and lymphoma shortly after the first  
publications. One of the first applications of interphase 
cytogenetics was the examination of patients with sex- 
mismatched bone marrow transplantation (Van Dekken 






